Therapeutic Advancements in Multiple Myeloma

Multiple myeloma survival has significantly improved in the latest years due to a broad spectrum of novel agents available for treatment. The introduction of thalidomide, bortezomib, and lenalidomide together with autologous stem-cell transplantation has considerably increased complete remission rat...

Descripción completa

Detalles Bibliográficos
Autores principales: Gozzetti, Alessandro, Candi, Veronica, Papini, Giulia, Bocchia, Monica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154387/
https://www.ncbi.nlm.nih.gov/pubmed/25237651
http://dx.doi.org/10.3389/fonc.2014.00241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154387/
https://www.ncbi.nlm.nih.gov/pubmed/25237651
http://dx.doi.org/10.3389/fonc.2014.00241

Ejemplares similares